Press "Enter" to skip to content

New patent for Arbor Pharms drug SKLICE

1
Copyright © DrugPatentWatch. Originally published at New patent for Arbor Pharms drug SKLICE

Annual Drug Patent Expirations for SKLICE
Annual Drug Patent Expirations for SKLICE

Sklice is a drug marketed by Arbor Pharms Llc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

SKLICE drug price trends.

Drug patent litigation for SKLICE.

This drug has twenty-six patent family members in thirteen countries.

The generic ingredient in SKLICE is ivermectin. One supplier is listed for this compound. Additional details are available on the ivermectin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Arbor Pharms drug SKLICE

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!